Cargando…

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions, including immune-mediated diseases. We investigated the association of C4 CN with systemic sclerosis (SSc) risk. Imputed total C4, C4A, C4B, and HERV-K CN were analyzed in 26,633 individuals and validated in an i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerick, Martin, Acosta-Herrera, Marialbert, Simeón-Aznar, Carmen Pilar, Callejas, José Luis, Assassi, Shervin, Proudman, Susanna M., Nikpour, Mandana, Hunzelmann, Nicolas, Moroncini, Gianluca, de Vries-Bouwstra, Jeska K., Orozco, Gisela, Barton, Anne, Herrick, Ariane L., Terao, Chikashi, Allanore, Yannick, Fonseca, Carmen, Alarcón-Riquelme, Marta Eugenia, Radstake, Timothy R. D. J., Beretta, Lorenzo, Denton, Christopher P., Mayes, Maureen D., Martin, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534873/ https://www.ncbi.nlm.nih.gov/pubmed/36198672 http://dx.doi.org/10.1038/s41525-022-00327-8

Ejemplares similares

Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes
por: Acosta-Herrera, Marialbert, et al.
Publicado: (2021)

The Effect of Body Fat Distribution on Systemic Sclerosis
por: Villanueva-Martin, Gonzalo, et al.
Publicado: (2022)

GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
por: López-Isac, Elena, et al.
Publicado: (2019)

Genetics of scleroderma: implications for personalized medicine?
por: Assassi, Shervin, et al.
Publicado: (2013)

Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need
por: Herrick, Ariane L., et al.
Publicado: (2022)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
por: Hanson, Aimee L., et al.
Publicado: (2022)

Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study
por: Rodriguez-Martin, Inmaculada, et al.
Publicado: (2023)

A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
por: López-Isac, Elena, et al.
Publicado: (2014)

Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit
por: Kakkar, Vishal, et al.
Publicado: (2022)

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations
por: Hoa, S., et al.
Publicado: (2016)

Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
por: Broen, JCA, et al.
Publicado: (2010)

A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
por: Broen, Jasper CA, et al.
Publicado: (2011)

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

FLT3 functional low-frequency variant rs76428106-C is associated with susceptibility to systemic sclerosis
por: Martínez-López, Javier, et al.
Publicado: (2022)

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study
por: Morrisroe, Kathleen, et al.
Publicado: (2016)

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis
por: Takata, Miki, et al.
Publicado: (2019)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
por: Carmona, F. David, et al.
Publicado: (2013)

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study
por: Mihai, Carina, et al.
Publicado: (2020)

GWAS loci associated with Chagas cardiomyopathy influences DNA methylation levels
por: Casares-Marfil, Desiré, et al.
Publicado: (2021)

KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor
por: Bossini-Castillo, Lara, et al.
Publicado: (2012)

Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients
por: Beretta, Lorenzo, et al.
Publicado: (2020)

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
por: Khanna, Dinesh, et al.
Publicado: (2023)

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study
por: Osthoff, Michael, et al.
Publicado: (2014)

Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Systemic sclerosis in the time of COVID-19
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2022)

Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc
por: Bellocchi, Chiara, et al.
Publicado: (2023)

The Role of Type 1 Interferon in Systemic Sclerosis
por: Wu, Minghua, et al.
Publicado: (2013)

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study
por: Esposito, James, et al.
Publicado: (2016)

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
por: Morrisroe, Kathleen, et al.
Publicado: (2017)

Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival
por: Morrisroe, Kathleen, et al.
Publicado: (2022)

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort
por: Nikpour, Mandana, et al.
Publicado: (2011)

Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden
por: Morrisroe, Kathleen, et al.
Publicado: (2019)

Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
por: Assassi, Shervin, et al.
Publicado: (2022)

Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review
por: Fritzler, Marvin J., et al.
Publicado: (2023)

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
por: Farutin, Victor, et al.
Publicado: (2021)

Quantitative videocapillaroscopy correlates with functional respiratory parameters: a clue for vasculopathy as a pathogenic mechanism for lung injury in systemic sclerosis
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2018)

Roles of cytotoxic lymphocytes and MIC/LILR families in pathophysiology of Takayasu arteritis
por: Yoshifuji, Hajime, et al.
Publicado: (2020)

The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review
por: Ishikawa, Yuki, et al.
Publicado: (2020)

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study
por: Ngian, Gene-Siew, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_85vo1i5768hkcr670q0pjdj132